Relationships of decreased lung function with metabolic syndrome and obstructive sleep apnea in Japanese males

Internal Medicine

Volumn 51, Issue 17, 2012, Pages 2291-2297

  Yoshimura, Chikara ^a   Oga, Toru ^a   Chin, Kazuo ^a   Takegami, Misa ^a   Takahashi, Ken ichi ^b   Sumi, Kensuke ^c   Nakamura, Takaya ^d   Nakayama Ashida, Yukiyo ^a   Minami, Itsunar ^a   Horita, Sachiko ^e   Oka, Yasunori ^f   Wakamura, Tomoko ^a   Fukuhara, Shunichi ^a   Michiaki, Mishima ^a   Kadotani, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OTSU RED CROSS HOSPITAL   (Japan)

^c National Hospital Organization Minami Kyoto Hospital   (Japan)

^d KYOTO CITY HOSPITAL   (Japan)

^e Sonoda Women's University   (Japan)

^f EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidemiologic study; Lung function; Metabolic syndrome; Obstructive sleep apnea

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOME MONITORING; HUMAN; HYPERGLYCEMIA; JAPANESE; LUNG FUNCTION; MALE; METABOLIC SYNDROME X; RISK FACTOR; SLEEP DISORDERED BREATHING; SMOKING; SPIROMETRY; WAIST CIRCUMFERENCE;

ADULT; CROSS-SECTIONAL STUDIES; FORCED EXPIRATORY VOLUME; HEALTH SURVEYS; HUMANS; HYPERGLYCEMIA; JAPAN; LUNG; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; SLEEP APNEA, OBSTRUCTIVE; VITAL CAPACITY;

EID: 84867800772     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7427     Document Type: Article

References (39)

1. Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M. Ventilatoryfunction impairment and risk of cardiovascular death and of fatalor non-fatal myocardial infarction. Eur Respir J 4: 1080-1087,1991.
2. Lee HM, Chung SJ, Lopez VA, Wong ND. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes.Chest 136: 171-176, 2009.
3. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in thegeneral population: 29-year follow-up of the Buffalo Health Study.Chest 118: 656-664, 2000.
4. Sin DD, Wu L, Man SF. The relationship between reduced lungfunction and cardiovascular mortality: a population-based studyand a systematic review of the literature. Chest 127: 1952-1959,2005.
5. Lee HM, Truong ST, Wong ND. Evidence of lung function forstratification of cardiovascular disease risk. Korean Circ J 41: 171-174, 2011.
6. Schnabel E, Karrasch S, Schulz H, et al. High blood pressure, antihypertensivemedication and lung function in a general adultpopulation. Respir Res 12: 50, 2011.
7. Hickson DA, Burchfiel CM, Liu J, et al. Diabetes, impaired glucosetolerance, and metabolic biomarkers in individuals with normalglucose tolerance are inversely associated with lung function:the Jackson Heart Study. Lung 189: 311-321, 2011.
8. Park HY, Lim SY, Hwang JH, et al. Lung function, coronary arterycalcification, and metabolic syndrome in 4905 Korean males. Respir Med 104: 1326-1335, 2010.
9. Salome CM, King GG, Berend N. Physiology of obesity and effectson lung function. J Appl Physiol 108: 206-211, 2010.
10. Lin WY, Yao CA, Wang HC, Huang KC. Impaired lung functionis associated with obesity and metabolic syndrome in adults. Obesity(Silver Spring) 14: 1654-1661, 2006.
11. Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, MunakataH. A possible association between suspected restrictive patternas assessed by ordinary pulmonary function test and themetabolic syndrome. Chest 134: 712-718, 2008.
12. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndromeis associated with some components of metabolic syndrome.Chest 131: 1387-1392, 2007.
13. Lim SY, Rhee EJ, Sung KC. Metabolic syndrome, insulin resistanceand systemic inflammation as risk factors for reduced lungfunction in Korean nonsmoking males. J Korean Med Sci 25:1480-1486, 2010.
14. Leone N, Courbon D, Thomas F, et al. Lung function impairmentand metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 179: 509-516, 2009.
15. Veale D, Chailleux E, Hoorelbeke-Ramon A, et al. Mortality ofsleep apnoea patients treated by nasal continuous positive airwaypressure registered in the ANTADIR observatory. Eur Respir J 15:326-331, 2000.
16. Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B. Determinants of hypercapnia in obese patients with obstructivesleep apnea: a systematic review and metaanalysis of cohort studies.Chest 136: 787-796, 2009.
17. Bradley TD, Rutherford R, Lue F, et al. Role of diffuse airwayobstruction in the hypercapnia of obstructive sleep apnea. Am RevRespir Dis 134: 920-924, 1986.
18. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonaryhemodynamics in the obstructive sleep apnea syndrome.Results in 220 consecutive patients. Chest 109: 380-386, 1996.
19. Lederer DJ, Jelic S, Basner RC, Ishizaka A, Bhattacharya J. CirculatingKL-6, a biomarker of lung injury, in obstructive sleep apnoea. Eur Respir J 33: 793-796, 2009.
20. Aihara K, Oga T, Harada Y, et al. Comparison of biomarkers ofsubclinical lung injury in obstructive sleep apnea. Respir Med105: 939-945, 2011.
21. Golbidi S, Badran M, Ayas N, Laher I. Cardiovascular consequencesof sleep apnea. Lung 190: 113-132, 2011.
22. Hoffstein V, Oliver Z. Pulmonary function and sleep apnea. SleepBreath 7: 159-165, 2003.
23. Nakayama-Ashida Y, Takegami M, Chin K, et al. Sleep-disorderedbreathing in the usual lifestyle setting as detected with homemonitoring in a population of working men in Japan. Sleep 31:419-425, 2008.
24. Chin K, Oga T, Takahashi K, et al. Associations between obstructivesleep apnea, metabolic syndrome, and sleep duration, asmeasured with an actigraph, in an urban male working populationin Japan. Sleep 33: 89-95, 2010.
25. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force.Standardisation of spirometry. Eur Respir J 26: 319-338, 2005.
26. Japanese Respiratory Society. Reference values of spirogram andarterial blood gas levels in Japanese. Jpn J Thoracic Dis 39: appendix,2001 (in Japanese).
27. Definition and the diagnostic standard for metabolic syndrome.Committee to Evaluate Diagnostic Standards for Metabolic Syndrome.Nihon Naika Gakkai Zasshi 94: 794-809, 2005 (in Japanese)
28. Executive Summary of the Third Report of the National CholesterolEducation Program (NCEP). Expert panel on detection,evaluation, and treatment of high blood cholesterol in adults (adulttreatment panel III). JAMA 285: 2486-2497, 2001.
29. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactiveprotein: another component of the atherothrombotic profile of abdominalobesity. Arterioscler Thromb Vasc Biol 21: 961-967,2001.
30. Ochs-Balcom HM, Grant BJ, Muti P, et al. Pulmonary functionand abdominal adiposity in the general population. Chest 129:853-862, 2006.
31. Nascimento MM, Qureshi AR, Stenvinkel P, et al. Malnutritionand inflammation are associated with impaired pulmonary functionin patients with chronic kidney disease. Nephrol Dial Transplant19: 1823-1828, 2004.
32. Yoon SH, Choi NW, Yun SR. Pulmonary dysfunction is possibly amarker of malnutrition and inflammation but not mortality in patientswith end-stage renal disease. Nephron Clin Pract 111: c1-c6,2009.
33. Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ. Associationbetween glycemic state and lung function: the FraminghamHeart Study. Am J Respir Crit Care Med 167: 911-916,2003.
34. Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review ofthe association between lung function and Type 2 diabetes mellitus.Diabet Med 27: 977-987, 2010.
35. Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation insmokers is associated with subclinical atherosclerosis. Am JRespir Crit Care Med 179: 35-40, 2009.
36. Barr RG, Ahmed FS, Carr JJ, et al. Subclinical atherosclerosis,airflow obstruction and emphysema: the MESA lung study. EurRespir J 39: 846-854, 2012.
37. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease inobstructive sleep apnoea syndrome: the role of intermittent hypoxiaand inflammation. Eur Respir J 33: 1195-1205, 2009.
38. Soriano JB, Zielinski J, Price D. Screening for and early detectionof chronic obstructive pulmonary disease. Lancet 374: 721-732,2009.
39. Quintana-Gallego E, Villa-Gil M, Carmona-Bernal C, et al. Homerespiratory polygraphy for diagnosis of sleep-disordered breathingin heart failure. Eur Respir J 24: 443-448, 2004.